|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.85 TWD | -0.26% |
|
-0.79% | -0.66% |
Meribank Biotech Co., Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 234.34 million compared to TWD 180.12 million a year ago. Net loss was TWD 125.35 million compared to TWD 102.13 million a year ago.
Basic loss per share from continuing operations was TWD 1.99 compared to TWD 1.63 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -0.66% | 82.81M | |
| +24.66% | 88.38B | |
| -21.76% | 77.56B | |
| +1.76% | 26.97B | |
| -13.50% | 16.57B | |
| +3.23% | 15.81B | |
| +77.51% | 13.65B | |
| +76.96% | 13.06B | |
| +4.72% | 12.61B | |
| +36.67% | 12.56B |
MERIBANK BIOTECH CO., LTD 
